These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10976279)

  • 1. [Methodological approaches to the study of the carcinogenic properties of substances].
    Pylev LN; Vasil'eva LA; Pliss GB
    Vopr Onkol; 2000; 46(3):320-6. PubMed ID: 10976279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract]   [Full Text] [Related]  

  • 3. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The methodology of an experimental study of the carcinogenicity of jointly acting chemical agents].
    Katul'skiĭ IuN
    Vopr Onkol; 1990; 36(7):785-91. PubMed ID: 2399657
    [No Abstract]   [Full Text] [Related]  

  • 5. [Method of studying the potential carcinogenic properties of food products].
    Neĭman IM; Kozlova IN
    Vopr Pitan; 1980; (1):58-61. PubMed ID: 7376557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of cancer assays for pharmaceutical agents.
    Ciminera JL; Heyse JF; Mantel N; Pitot PC
    J Natl Cancer Inst; 1984 Jun; 72(6):1212. PubMed ID: 6587143
    [No Abstract]   [Full Text] [Related]  

  • 7. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundamental carcinogenic processes and their implications for low-dose risk assessment.
    Mantel N
    Cancer Res; 1978 Jun; 38(6):1835-8. PubMed ID: 647692
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxicity from the complex action and the possibility of carcinogenic and cocarcinogenic properties of triethanolamine].
    Kostrodymova GM; Voronin VM; Kostrodymov NN
    Gig Sanit; 1976 Mar; (3):20-5. PubMed ID: 1269952
    [No Abstract]   [Full Text] [Related]  

  • 11. [The carcinogenic and anticarcinogenic properties of neozon D].
    Pliss GB; Vlasov NN; Zabezhinskiĭ MA
    Vopr Onkol; 1991; 37(1):60-4. PubMed ID: 2014680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncertainty estimates for low-dose-rate extrapolations of animal carcinogenicity data.
    Guess H; Crump K; Peto R
    Cancer Res; 1977 Oct; 37(10):3475-83. PubMed ID: 908002
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxicological aspects of evaluation of carcinogenic activity of chemical substances].
    Sanotskiĭ IV; Sal'nikova LS
    Vopr Onkol; 1983; 29(12):83-6. PubMed ID: 6666102
    [No Abstract]   [Full Text] [Related]  

  • 16. Basic requirements for long-term assays for carcinogenicity.
    Feron VJ; Grice HC; Griesemer R; Peto R; Agthe C; Althoff J; Arnold DL; Blumenthal H; Cabral JR; Della Porta G; Ito N; Kimmerle G; Kroes R; Mohr U; Napalkov NP; Odashima S; Page NP; Schramm T; Steinhoff D; Sugar J; Tomatis L; Uehleke H; Vouk V
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):21-83. PubMed ID: 6935180
    [No Abstract]   [Full Text] [Related]  

  • 17. [Carcinogenic activity of some Soviet drug preparations].
    Tsapenko VF; Boĭm TM; Osin'kovskaia ND; Rubenchik BL
    Eksp Onkol; 1986; 8(3):75-6, 78. PubMed ID: 3720645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations in the conduct of meta-analysis using data from animal carcinogenicity experiments.
    McKnight B
    IARC Sci Publ; 1992; (116):557-69. PubMed ID: 1428098
    [No Abstract]   [Full Text] [Related]  

  • 20. Incorporating the concept of 'invaders' and 'defenders' in the dose-response modeling of carcinogens.
    Stevenson DE; Sielken RL
    Prog Clin Biol Res; 1995; 391():445-51. PubMed ID: 8532736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.